Text Size:   A+ A- A   •   Text Only
Find     
Site Image

ARCHIVES
ARCHIVES

SEARCH
Click here to search the Oregon Board of Pharmacy Website. 

2015 - Items that first appeared as Items of Interest or What's Hot in 2015

 
 

2014 - Items that first appeared as Items of Interest or What's Hot in 2014

 
 
2013 - Items that first appeared as Items of Interest or What's Hot in 2013
 

2012 - Items that first appeared as Items of Interest or What's Hot in 2012

Fungal Meningitis & New England Compounding Center - 10/22/12
Prescription Fraud & Robbery Best Practices

2011 - Items that first appeared as Items of Interest or What's Hot in 2011 
 
Board Conducted Survey on Working Conditions...See Results -11/17/11  
 
Oregon PDMP System Goes Online - September 1, 2011  
Clarification from the DEA - 5/9/11 
Board bans Dangerous Synthetic Cannabis and Mephedrone 4/11  
Impaired Health Professionals Program (HPSP) - DHS  
DEA: Temporary placement - 5 Synthetic Cannabinoids Into Sched. 1 
  
2010 - Items that first appeared as Items of Interest or What's Hot in 2010

Impaired Health Professionals Program (HPSP) - DHS 7/10  
Note to Long Term Care Facilites: DEA Drug Loss Reports 1/10 
 

2009 - Items that first appeared as Items of Interest or What's Hot in 2009
 
FDA Extends Tamiflu Expiration Dates - 10/09
State Emergency Registry of Volunteers in Oregon (SERV-OR)
Tamiflu Information - Updated 10/28/09 
FDA alert re: stolen Astellas Prescription Drug Products - 7/09 
Swine Flu - April 27, 2009  

   
2008 - Items that first appeared as Items of Interest or What's Hot in 2008

Human Rabies Vaccine Shortage
Proper Disposal of Prescription Drugs
Exception Requirements and Rule Changes
Tamper Resistant Prescription Requirements - Effective 4/1/08
Changes that may be made to a CII prescription - 3/08
Summary of Electronic Prescribing Regulations
**Methadone Advisory**
DEA Rule - Multiple C-II Prescriptions Written on the Same Date
 
 

2005-2007 - Other News & Information 
 
FDA Warning - Counterfeit Drug Sales - May, 2007
Death with Dignity Act Reporting Requirements 
Internet Pharmacies 
Pharmacist alterations allowed on Schedule II Prescriptions  
Notifying prescriber when making changes to a prescription 
 

Foreign Drug Importation Issues

Testimony of Executive Director to the National Senate Special Committe on Aging, January 26, 2005
Governor Announces Three-Part Effort to Help Oregonians Afford Prescription Drugs
Laws Prohibiting Canadian Drug Imports